Seelos Therapeutics, Inc. (NASDAQ: SEEL) announced today that it has entered into a securities purchase agreement with certain institutional investors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE